| AJADUO | EMPAGLIFLOZIN + LINAGLIPTIN |   |
| BUDAMATE | BUDESONIDE + FORMOTEROL |   |
| CETIL | CEFUROXIME AXETIL |  |
| CIDMUS | SACUBITRIL + VALSARTAN |  |
| CLOPITAB | CLOPIDOGREL BISULFATE |  |
| FERINJECT | IRON FERRIC CARBOXYMALTOSE |  |
| GIBTULIO | EMPAGLIFLOZIN |  |
| GLUCONORM-G | GLIMEPIRIDE + METFORMIN |  |
| HUMINSULIN | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT |  |
| IVABRAD | IVABRADINE |   |
| LUPIHEME | IRON METAL |  |
| LUPISULIN-M | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT |  |
| MEROTROL | MEROPENEM |  |
| ONDERO | LINAGLIPTIN |   |
| RABLET | RABEPRAZOLE |   |
| SIGNOFLAM | ACECLOFENAC + PARACETAMOL + SERRAPEPTASE |  |
| TAZAR | PIPERACILLIN + TAZOBACTAM |  |
| TELEKAST-L | LEVOCETIRIZINE + MONTELUKAST |  |
| TONACT | ATORVASTATIN |   |
Pingback: USFDA approves Lupin’s Posaconazole tablets > PharmaCampus